2 citations
,
July 2021 in “Uro” This review discusses the efficacy of the lipidosterolic extract of Serenoa repens for treating lower urinary tract symptoms and reports no new clinical results; the authors propose further examination of the existing literature and guidelines.
2 citations
,
December 2019 in “Cureus” This report describes a case of secondary cutis verticis gyrata due to a cerebriform intradermal nevus, highlighting clinical management and screening guidelines.
2 citations
,
April 2019 in “Proceedings of Singapore Healthcare” This study found that a collaborative care model in rheumatoid arthritis clinics improved nb-DMARD dose optimization, adherence to monitoring guidelines, and detection of related adverse drug events compared to standard care.
2 citations
,
January 2019 in “PubMed” This study examined the follicular unit density in the scalp and beard donor areas of Indian men undergoing hair restoration surgery, reporting mean densities of 78.2/cm² and 49.7/cm² respectively, and proposed guidelines for safe follicular unit extraction.
2 citations
,
December 2014 in “Journal of primary health care” This review of polycystic ovary syndrome cases in New Zealand suggests a need for improved recording of diagnostic criteria, as general practitioners often rely on ultrasounds despite guidelines advising otherwise.
1 citations
,
August 2024 in “Journal of Cosmetic Dermatology” This study found that while overall differences are minimal, oscillatory punches are significantly more effective than rotary punches for cases requiring hair extraction through soft scalps or deeper punches, and following structured guidelines can improve outcomes.
1 citations
,
January 2021 This review covers the use of platelet-rich plasma in dermatology for wound healing, hair restoration, skin rejuvenation, and dermal augmentation, and notes the need for standardized guidelines.
1 citations
,
December 2017 This review found that androgenetic alopecia may be linked to increased cardiovascular and metabolic risks, but the relationship is not yet fully understood, and specific guidelines for cardiovascular disease detection and prevention in these patients have not been established.
1 citations
,
June 1999 in “American Journal of Contact Dermatitis” This review discusses the choice and formulation of medicated and cosmetic shampoos for scalp disorders and hair aesthetics, providing guidelines based on hair types and patient age, and reports no new results.
August 2026 in “Orvosi Hetilap” In this study, researchers reported that while conventional treatments like topical minoxidil remain fundamental for androgenetic alopecia, guidelines increasingly support low-dose oral minoxidil and dutasteride, though their recommendations vary. Personalized multimodal treatment strategies and regular follow-ups are essential in clinical practice.
August 2026 in “Journal of Clinical Medicine” In this study, researchers found that the management of alopecia areata in Poland is inadequate, despite following international guidelines, due to limited access to advanced treatments and insufficient use of severity assessments and psychosocial support.
June 2026 in “Dermatology and Skin Science” This study highlights that acne is a common issue for transgender men undergoing testosterone therapy, with management generally following similar guidelines as for cisgender individuals.
In this review, researchers explain various hair loss treatments in South Africa, detailing how they work, who can use them, possible side effects, and guidelines for safe application, helping readers make informed decisions about hair care.
May 2026 in “International Journal of Creative and Open Research in Engineering and Management” This review reports that nutritional and lifestyle factors, such as micronutrient deficiencies and stress, play a significant role in hair health and loss, but emphasizes that evidence for interventions remains limited and more research is needed to establish clear clinical guidelines.
May 2026 in “Actas Dermo-Sifiliográficas” This review highlighted current treatments for androgenetic alopecia and proposed a management algorithm, noting additional therapies show effectiveness but lack inclusion in official guidelines due to the absence of randomized clinical trials.
April 2026 in “Russian Journal of Skin and Venereal Diseases” This review reports that hyperandrogenic conditions in women, which affect skin and overall well-being, lack dedicated treatment guidelines, presenting challenges in standardizing care.
February 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This review discusses advancements in understanding the genetic and stem cell involvement in androgenetic alopecia, evaluates current treatments, and emphasizes the need for evidence-based guidelines but presents no new clinical results.
January 2026 in “Skin Health and Disease” This study conducted a survey among consultant dermatologists in Ireland to explore their use of JAK inhibitors for treating alopecia areata, acknowledging challenges posed by the lack of global guidelines and long-term safety data.
December 2025 in “Eastern Ukrainian Medical Journal” This study reviews current methods for making and using platelet-rich plasma and fibrin, emphasizing the variability in clinical outcomes due to differences in preparation protocols, and calls for standardized guidelines and large-scale studies for better effectiveness in regenerative medicine.
December 2025 in “Journal of Inflammation Research” This study highlights ongoing inequities in access and outcomes for inflammatory skin diseases in Latin America and emphasizes the need for regional registries, harmonized clinical guidelines, and policy reforms to improve equitable dermatologic care.
October 2025 in “International Journal of Innovative Research in Technology” This review examines the evidence on nutritional and herbal supplements for women's health, emphasizing the need for more long-term studies to develop evidence-based guidelines for personalized supplementation.
August 2025 in “Advances in Therapy” In this study, the researchers noted that physicians in China prioritize clinical hyperandrogenism when making PCOS treatment decisions, highlighting a need to align clinical practices with guidance recommendations and to clarify the role of biochemical hyperandrogenism in future guidelines.
June 2025 in “British Journal of Dermatology” This study surveyed Irish dermatologists and found that while JAK inhibitors show promising efficacy for alopecia areata, there is significant variation in practice due to the lack of specific guidelines and long-term safety data for these treatments.
June 2025 in “Journal of Endocrinological Investigation” This review identifies and discusses various endocrine-related causes of hypertension in children and adolescents, emphasizing the role of genetic predispositions and highlighting the need for systematic diagnostic guidelines and genetic sequencing referrals to improve diagnosis and treatment strategies.
This review examines clinical studies on the effectiveness of biotin in treating hair loss, detailing its role in hair health, recommended usage guidelines, and potential side effects, aiding physicians and patients interested in hair loss prevention and treatment.
March 2025 in “Journal of Investigative Dermatology” This study found that while children's books on alopecia and trichotillomania exist, they often do not fully cover treatment guidelines set by the American Academy of Dermatology and the American Journal of Psychiatry, highlighting a need for more comprehensive resources to support affected children's well-being.
February 2025 in “Journal of Pre-Clinical and Clinical Research” This source reports that combining 5-alpha reductase inhibitors with minoxidil for treating male androgenic alopecia presents a minimal risk of side effects when administered following established medical guidelines, with finasteride commonly associated with reversible sexual side effects and dutasteride used off-label with similar risks.
January 2025 in “JDDG Journal der Deutschen Dermatologischen Gesellschaft” This study surveyed German dermatologists about treating children and adolescents with alopecia areata, revealing significant emotional challenges like bullying and low self-esteem, dissatisfaction with available treatments, and a need for both psychological support and new therapeutic guidelines.
January 2025 in “NATIONS UNIVERSITY INTERNATIONAL JOURNAL OF MULTI-DISCIPLINARY STUDIES” This study found that only 48% of the medicinal plant uses reported by people in Lithuania's Marijampole region align with European Medicines Agency guidelines, highlighting the need for further evaluation of ethnopharmacological practices.
January 2025 in “Geneesmiddelenbulletin” This 104-week follow-up trial found that baricitinib is effective and safe for treating severe alopecia areata but requires continuous use to sustain hair regrowth. The drug is included in the NVDV guidelines and reimbursed by Dutch insurers for this purpose.